Welcome to our dedicated page for Ingersoll Rand news (Ticker: IR), a resource for investors and traders seeking the latest updates and insights on Ingersoll Rand stock.
Ingersoll Rand Inc. reports developments tied to its mission-critical flow creation, life science and industrial solutions portfolio. Company news commonly covers operating results, order and revenue trends, segment performance, and regular capital-return actions such as cash dividends.
Updates also include bolt-on acquisitions that expand technologies within areas such as metering and dosing, compression, blower and vacuum, and fluid management. Recent acquisition activity added hydropneumatic accumulators, pulsation dampeners, calibration pots and instrumentation to the Precision and Science Technologies segment. Other recurring announcements address sustainability recognition, investor conference participation, governance matters and business outlook commentary.
Ingersoll Rand (NYSE: IR) declared a regular quarterly cash dividend of $0.02 per share, payable on June 4, 2026 to stockholders of record on May 14, 2026. The dividend applies to common stock and is a routine cash distribution to shareholders.
Ingersoll Rand (NYSE: IR) will release Q1 2026 earnings after market close on Tuesday, April 28, 2026 and host a live conference call on Wednesday, April 29, 2026 at 8:00 a.m. ET. Related presentation materials and a real-time webcast will be posted on the Investor Relations website, with a replay available after the call.
Ingersoll Rand (NYSE: IR) received multiple sustainability recognitions in early 2026, including a CDP A List rating (as of Jan 6, 2026) and an 82/100 score on the 2025 S&P Global Corporate Sustainability Assessment (as of Feb 11, 2026).
The company ranked #1 in North America and in the top 5% globally in its industry, was included in the Dow Jones Best-in-Class Indices for the fourth consecutive year, and placed #2 on 3BL Media’s 100 Best Corporate Citizens of 2025.
Ingersoll Rand (NYSE: IR) reported strong fourth-quarter and full-year 2025 results with Q4 orders of $1,952M (+8%) and revenues of $2,091M (+10%). Q4 adjusted net income was $382M ($0.96/share), up 14%, and adjusted EBITDA was $580M (27.7% margin). Full‑year 2025 adjusted EBITDA was $2,094M with free cash flow of $1,220M and liquidity of $3.8B. Management issued 2026 guidance: revenue growth of 2.5–4.5%, adjusted EBITDA of $2,130–$2,190M, and adjusted EPS of $3.45–$3.57.
Ingersoll Rand (NYSE: IR) declared a regular quarterly cash dividend of $0.02 per share, payable March 26, 2026, to stockholders of record on March 4, 2026. The dividend continues the company's program of returning cash to shareholders via quarterly distributions.
Ingersoll Rand (NYSE: IR) announced that Vik Kini, chief financial officer, will participate in fireside chats at upcoming investor conferences: The Barclays Industrial Select Conference on Wednesday, February 18, 2026 at 9:50 a.m. ET and The Citi Global Industrial Tech and Mobility Conference on Thursday, February 19, 2026 at 8:50 a.m. ET. A real-time audio webcast of both sessions will be available via the Events and Presentations section of the Ingersoll Rand Investor Relations website, and a replay will be posted after each fireside chat concludes.
Summary not available.
Ingersoll Rand (NYSE: IR) will release its Q4 2025 earnings after market close on February 12, 2026 and will host a live conference call to discuss results on February 13, 2026 at 8:00 a.m. ET. Participants can join by dialing +1-888-330-3073 (U.S.) or +1-646-960-0683 (international) using access code 8970061.
A real-time audio webcast and related materials will be posted in the Events and Presentations section of the Ingersoll Rand Investor Relations website prior to the call, and a replay will be available after the conference concludes.
Ingersoll Rand (NYSE: IR) acquired Scinomix, a U.S.-based designer and manufacturer of lab automation technologies, on Jan. 5, 2026 to expand its life sciences portfolio. The deal integrates Scinomix into the Precision and Science Technologies Life Sciences platform and aims to deliver end-to-end solutions for sample management, labeling, barcode scanning, handling, and capping across clinical, pharma, biotech, forensic, agricultural, and genetic testing labs.
The company said the purchase was made at an attractive pre-synergy multiple of ~10x 2025 Adjusted EBITDA, and management highlighted scalable automation, improved throughput, accuracy, and traceability as strategic benefits.
Ingersoll Rand (NYSE: IR) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 7:30 a.m. Pacific Time. Senior management attending includes chairman & CEO Vicente Reynal, CFO Vik Kini, and Scott Watson, SVP and GM, Life Science Technologies.
A real-time audio webcast of the fireside chat will be available via the Events and Presentations section of the Ingersoll Rand Investor Relations website, and a replay will be posted after the presentation.